The mechanisms responsible for cytokinemediated antiviral effects are not fully understood. We approached this problem by studying the outcome of intraocular herpes simplex (HSV) infection in transgenic mice that express interferon y in the photoreceptor cells of the retina. These transgenic mice showed selective survival from lethal HSV-2 infection manifested in both eyes, the optic nerve, and the brain. Although transgenic mice developed greater inflammatory responses to the virus in the eyes, inflammation and viral titers in their brains were equivalent to nontransgenic mice. However, survival of transgenic mice correlated with markedly lower numbers of central neurons undergoing apoptosis. The protooncogene Bcl2 was found to be induced in the HSV-2-infected brains of transgenic mice, allowing us to speculate on its role in fostering neuronal survival in this model. These observations imply a complex interaction between cytokine, virus, and host cellular factors. Our results suggest a cytokine-regulated salvage pathway that allows for survival of infected neurons.
Immune responses to viruses in the central nervous system (CNS) are not fully understood but involve the action of several cytokines that contribute to the development of pathology. The pleiotropic cytokine interferon y (IFN-,y) may have an important role in this process. IFN-y has the capacity to activate macrophages, natural killer cells, as well as B and T lymphocytes (1) . This cytokine also plays a crucial role in experimentally induced allergic encephalitis (2) and induces expression of major histocompatibility complex class I and class II antigens on astrocytes and microglia (3) (4) (5) . The antiviral activities of IFN-'y have been attributed mainly to influences on the replication of viruses (6) (7) (8) (9) (10) .
We have previously studied the effects of IFN-'y on herpes simplex virus type 1 (HSV-1) infection of the CNS using transgenic mice that express IFN--y restricted to the photoreceptors of the retina (rho y mice) (11). We found that the ectopic expression of IFN--y provided protection for mice infected with HSV-1 strain F. This effect was associated with increased inflammation in the eyes of infected mice but did not influence the neuroinvasion by the virus or viral replication in the eyes and the brain (9). In contrast to the known harmful effects of IFN-,y on the brain the apparently lesser extent of morphological damage to the brain led us to suspect other mechanisms of neuronal protection afforded by IFN-'y.
To investigate this possibility, we tested the influence of intraocular IFN--y on the survival of mice after infection with the lethal HSV-2 strain 186 (12), which produced encephalitis in infected mice. The rhoy transgenic mice and nontransgenic mice received intravitreal injection of HSV-2 or HSV-1 strain F (13) as a control. Intravitreal inoculation of the virus leads
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to rapid viral spread to the brain without mechanical disruption of the blood-brain barrier. To investigate the mechanisms involved in the possible protective effects of IFN-,y, we quantitated infectious virus recovered from tissues of infected animals and studied the occurrence of apoptosis in the brain. We found that the increased survival in transgenic mice correlated with markedly decreased apoptosis in the brain. We further studied the expression of the protooncogene Bcl2, which has been associated with the prevention of apoptosis (14) and the regulation of survival of developing neurons (15) in the brain. We detected the up-regulation of Bc12 expression in the HSV-2-infected brains of transgenic mice, providing a clue to the mechanism for the observed survival.
MATERIALS AND METHODS Animals. We used BALB/c-derived rho-y transgenic mice and nontransgenic littermates between 4 and 6 weeks of age, with three to four age-matched animals used per group and time point. All experiments were repeated at least once. Transgenic animals were routinely screened for the transgene using PCR amplification of tail DNA.
Virus and Infection Protocol. HSV-1 and HSV-2, strain 186 (provided by R. Schrier, University of California at San Diego) were grown on Vero cells, plaque-purified, and titrated by using the plaque-forming assay (16). One microliter containing 2 x 105 plaque-forming units (pfu) of HSV-1 or 2 x 104 pfu of HSV-2 was injected into the vitreous humor of each animal's right eye as described (9). One microliter of IFN--y (Genentech; 1 (PharMingen) . Three brains per group were homogenized in 2 ml of PBS for 15 sec using a mechanical homogenizer (Ultra-Turrax; IKA). Cell debris was removed by 10-min centrifugation with 2000 rpm (Sorvall RT 6000B). The supernatant was used for ELISA.
To recover infectious virus, we homogenized tissues of eyes and brains of five mice per group separately in 400 or 1000 ,ul of PBS, respectively, as described above. Plaque assays were done on Vero cells with an incubation time of 60 min at 37°C, subsequent Dulbecco's modified Eagle medium (DMEM)/ agarose overlay, and development for 2 days. Viral yield was calculated from serial dilutions on plates yielding 10-100 plaques (9, 16).
RESULTS
Manifestations of Disease. All mice infected with HSV-1 survived the infection and developed pathology in eyes and brain, as described (9). All mice infected with HSV-2 became sick by day 5 or 6, displaying a rough coat, lethargy, abnormal stretching, and beginning ataxia as scored visually and by the capacity of limb usage. However, only the nontransgenic mice progressed to forelimb paralysis and seizures and died by day 7 or 8 from encephalitis. In contrast, infected transgenic mice survived and recovered completely from their symptoms by days 12-14. Nontransgenic mice treated with IFN-,y developed the same amount of macroscopic pathology as untreated animals but survived until day 9.
Histological and Immunohistochemical Assessment of the Eyes and Brains from Mice Infected with HSV-2. Morphological changes and viral antigen detected by immunostaining were evident in all inoculated eyes at day 3 after infection with HSV-2, including moderate cellular infiltration of the whole eye but only minor retinal destruction. By days 5-7 pathology and expression of viral antigen were seen in the brain, in both optic nerves with their enveloping sheaths, and in the uninfected eye of all intravitreally inoculated mice ( Fig. 1 A and B) . These changes correlated with considerable damage of the inner retina, choroidal swelling of the injected eye, and beginning destruction of the retina in the contralateral, uninjected eye. Eyes of transgenic mice showed the same amount of retinal damage but more inflammatory cells when compared with the eyes of control animals.
Virus-induced pathology in the brains consisted of a moderate increase of mononuclear cells, especially around vessels, expression of viral antigen, and neuronal damage. Some affected neurons had a swollen appearance, but shrunken cells with chromatin condensation and nuclear fragmentation, indicating apoptosis, were present as well. Pathological changes in the brain were correlated with the presence of viral antigen and were apparent in the lateral geniculate, the superior colliculus, and in the suprachiasmatic area (18). In the course of disease, the observed damage and the expression of viral antigen extended to the cortex, mostly associated with the visual pathway and the ventricular system. Nontransgenic animals appeared to have a higher degree of neuronal damage than transgenic mice.
The inflammatory response to infection with HSV-2 consisted of natural killer cells, macrophages, and T cells in the eyes and brains, as confirmed by immunostaining similar to earlier findings in HSV-1 infection (9). Rhoy mice showed a markedly stronger inflammation, involving all structures of the eyes, than did nontransgenic mice. Cell counts for L3T4-(CD4) and Ly2-positive cells (CD8) confirmed considerably higher numbers of both T-cell subsets in the eyes of transgenic mice than in control mice. However, the brains of both groups had virtually the same content of T cells (Fig. 2) . IFN-,y could not be detected in the brains of HSV-2-infected transgenic or nontransgenic mice by ELISA. (Fig. 4) encoded by the Bc12 gene has been correlated with protection 1000000 HSV-2/186, from programmed cell death, and we therefore studied Bc12
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HSV-2 reached equal levels of infectious virus in the brains of transgenic and nontransgenic mice. Nevertheless, transgenic mice survived the infection with only minor neurological disorders, whereas the control mice suffered from encephalitis and died. The factor correlating with survival of the rho'y mice was the decreased extent of apoptosis in their brains. The fact that a large number of the cells undergoing apoptosis were negative for HSV antigen makes it unlikely that the differences between transgenic and nontransgenic mice were caused predominantly by the action of cytotoxic T cells, which are known to induce this reaction in HSV-infected cells (19), especially because transgenic and nontransgenic mice have equal numbers of T cells in their brains and IFN-,y concentrations did not appear to increase.
Consistent with earlier reports investigating the spreading characteristics of HSV by immunostaining (18), we found viral antigen in the second eye by day 6 or 7 and found the antigen slightly earlier in the brain. However, the more sensitive method of viral recovery assay yielded infectious virus in the second eye and in the brain 1 day after infection. Therefore, viral spread must be much faster than previously thought. A possible explanation could rest with the assumption of higher numbers of infected macrophages than published for other viruses (20). Alternatively, viral spread to the brain could occur through the optic nerve sheaths via the cerebrospinal fluid, accounting for the unusual locations of the virus we found in the brain. However, precise determination of propagation mechanisms in the brain will need further study.
The observation of increased Bc12 expression in the CNS reflects a complex interaction between the cytokine, virus, and cellular factors elicited in neurons. Because Bc12 up-regulation was not seen in uninfected transgenic mice, it cannot be accounted for by a direct effect of IFN-,y. Indeed our results are counterintuitive because IFN-y has been associated with inducing apoptosis in vitro in multiple cell lines (3) (4) (5) . Likewise, the induction of the Bc12 gene is not the direct effect of HSV because in infected nontransgenic mice Bc12 is not hyperexpressed. Thus, our observations can only be accounted for by the cumulative interaction of virus and cytokine. One possibility is that exposure of the virus to the cytokine in the eye could impose either genetic selection or alteration of viral protein expression, which, in turn, can affect protooncogene expression by brain neurons. Alternatively, Bc12 up-regulation could result from a fundamental difference in the cytokineinfluenced inflammatory response. A parallel interaction where cytokines favor the expression of viral proteins that prevent apoptosis of infected neurons is known for Tat expression in human immunodeficiency virus infection (21) or p35 of baculoviruses (22) . Similarly, the latent membrane protein 1 of the Epstein-Barr virus (23) has been shown to up-regulate Bc12 and block apoptosis in infected B-cell lines. Here we demonstrate the significance of such regulation in vivo within the CNS, favoring neuronal survival over death. It is interesting to note that HSV-1 virions lacking the yl 34.5 gene cause a response similar to programmed cell death in neurons, suggesting that the yl 34.5 gene product might be critical for fostering such neuronal survival (24). Interestingly, in the case of the lethal HSV-2, the interference with programmed cell death observed here also requires exposure to IFN-,y. Whereas the antiviral activity of IFN-'y has previously been attributed to effects on viral replication or enhancement of the antigenspecific immune response, here we document that IFN-,y promotes survival of virus-infected neuronal cells by a distinct mechanism.
The mechanisms by which IFN-y influences Bc12 expression and programmed cell death in the brain need further experimental investigation. These findings warrant additional perspectives concerning infections by other viruses. Mechanisms superficially beneficial in acute viral infection of the CNS may ultimately allow for the survival of cells infected with multiple pathogenic viruses. Such viruses could affect the genetic programming of terminally differentiated cells and be deleterious to their function in a manner such as seen in postencephalitic neuronal disorders and AIDS dementia. Additionally these viral genomes may not remain quiescent forever, allowing reactivation and localized inflammatory reactions to endure beyond where the death and elimination of infected cells would allow.
